MORIN, A FLAVONOID, ON LIPID PEROXIDATION AND ANTIOXIDANT STATUS IN EXPERIMENTAL MYOCARDIAL ISCHEMIC RATS

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 11, Issue 3, 2014, Pages 14-20

  Al Numair, Khalid S ^a   Chandramohan, Govindasamy ^a   Alsaif, Mohammed A ^a   Veeramani, Chinnadurai ^a   El Newehy, Ahmed S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidants; Isoproterenol; Lipid peroxidation; Morin; Myocardial infarction

Indexed keywords

ANTIOXIDANT; FLAVONOID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MORIN; SUPEROXIDE DISMUTASE;

ANIMAL; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MYOCARDIAL INFARCTION; RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FLAVONOIDS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84964314233     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v11i3.3     Document Type: Article

References (55)

1. Al-Numair, K.S., Chandramohan, G. and Alsaif, M.A. (2012). Pretreatment with morin, a flavonoid, ameliorates adenosine triphosphatases and glycoproteins in isoproterenol induced myocardial infarction in rats. J. Nat. Med. 66: 5–101.
2. Al-Numair, K.S., Chandramohan, G., Alsaif, M.A. and Baskar, A.A. (2012). Protective effect of morin on cardiac mitochondrial function during isoproterenol induced myocardial infarction in male Wistar rats. Redox Report 7(1): 14–21.
3. Amy, D., Amico, D.D. and Beslo, D. (2003). Structure radical scavenging relationship of falconoid Corat. Chim. Acta 76: 55–61.
4. Anversa, P. and Sonnenblick, E.H. (1990). Ischemic cardiomyopathy: pathophysiologic mechanisms. Prog. Cardiovasc. Dis. 33: 49–70.
5. Baker, H., Frank, O., De Angelis, B. and Feingold, S. (1980). Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr. Rep. Int. 21: 531–536.
6. Benidich, A., Machlin, L.J. and Sundarrao, A. (1986). The antioxidant role of Vitamin C. Adv. Free Rad. Biol. Med. 224: 573–596.
7. Bhagat, B., Sullivan, J.M., Fischer, V.W., Nadel, E.M. and Dhalla, N.S. (1976). cAMP activity and isoproterenol-induced myocardial injury in rats. Recent Adv. Stud. Cardiac Struct. Metab. 12: 465–470.
8. Brown, J., O’prey, J. and Harrison, P.R. (2003). Enhanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways. Carcinogenesis 24: 171–177.
9. Chagoya De Sanchez, V., Hernandez-Munoz, R., Lopez-Barrera, F., Yanez, L., Vidrio, S., Suarez, J., Cota-Garza, M.D., Aranda-Fraustro, A. and Cruz, D. (1997). Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can. J. Physiol. Pharmacol. 75: 1300–1311.
10. Chen, Y., Li, X., Zhao, B., Zheng, R. and Xin, W. (1989). Superoxide and hydroxyl radical scavenging activities of rutin and other natural products studied by ESR. Biophys. Acta 5: 253–260.
11. Cook, N.C. and Samman, S. (1996). Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J. Nutr. Biochem. 7: 66–76.
12. Dhalla, N.S., Elmoselhi, A.B., Hata, T. and Makino, N. (2000). Status of myocardial antioxidants in ischemia–reperfusion injury. Cardiovasc. Res. 47: 446–456.
13. Ellman, G.C. (1959). Tissue sulfhydyl groups. Arch. Biochem. Biophys. 82: 70–77.
14. Ferrari, R., Agnoletti, L., Comini, L., Gaia, G. and Bachetti, T. (1998). Oxidative stress during myocardial ischemia and heart failure. Eur. Heart J. 19(Suppl B): B2
15. Ferrari, R., Alfieri, O., Curello, S., Ceconi, C. and Cargnoni, A. (1990). Occurrence of oxidative stress during reperfusion of the human heart. Circulatn 81: 201–211.
16. Flaherty, J.T. and Weisfeldt, M.L. (1988). Reperfusion injury. Free Radic. Biol. Med. 5: 409–419.
17. Fraga, C.G., Leibovitz, B.F. and Toppel, A.L. (1988). Lipid peroxidation measured as TBARS in tissue slices. Characterization and comparison with homogenate and microsomes. Free Rad. Biol. Med. 4: 155–161.
18. Francis, A.R., Shetty, T.K. and Bhattacharya, R.K. (1989). Modulating effect of plant flavonoids on the mutagenicity of N-methyl-NV-nitro-Nnitrosoguanidine. Carcinogenesis 10: 1953–1955.
19. Guarnieri, C., Flamigni, F. and Caldarera, C.M. (1980). Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart. J. Mol. Cell Cardiol. 12: 797–808.
20. Habig, W.H. and Jakoby, W.B. (1981). Assays for differentiation of glutathione-S-transferases. Meth. Enzymol. 77: 398–405.
21. Hill, M.F. and Singal, P.K. (1996). Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am. J. Pathol. 48: 291–300.
22. Hodek, P., Trefil, P. and Stiborova, M. (2002). Flavonoids-potent and versaltile biologically active compounds interacting with cytochromes P450. Chem. Bio. Interact. 139: 1–21.
23. Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J. and Der, C.J. (1997). Mitogenic signaling mediated by oxidants in ras-transformed fibroblast. Sci. 275: 1649–1652.
24. Ithayarasi, A.P. and Dev, C.S.S. (1997). Effect of alpha tochopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats. Indian J. Physiol. Pharmacol. 41: 369–376.
25. Jagetia, G.C., Reddy, T.K. and Kedlaya, R. (2004). Influence of naringin on ferric iron induced oxidative damage in vitro. Clin. Chim. Acta 347: 189–197.
26. Jayachandran, K.S., Vasanthi, H.R. and Rajamanickama, G.V. (2010). Flavonoid rich fraction of Dioscorea bulbifera Linn. (Yam) enhances mitochondrial enzymes and antioxidant status and thereby protects heart from isoproterenol induced myocardial infarction. Curr. Pharm. Biotechnol. 11(8): 887-894.
27. Jiang, Z.Y., Hunt, J.V. and Wolff, S.P. (1992). Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxides in low-density lipoprotein. Anal. Biochem. 202: 384–389.
28. Kakkar, P., Das, B. and Viswanathan, P.N. (1984). A modified spectrophotometric assay of SOD. Indian J. Biochem. Biophys. 21:130–132.
29. Kawabata, K., Tanaka, T., Honjo, S., Kakumoto, M., Hara, A., Makita, H., Tatematsu, N., Ushida, J., Tsuda, H. and Mori, H. (1999). Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis. Int. J. Cancer 83: 381–386.
30. Kitagawa, S., Sakamoto, H. and Tan, H. (2004). Inhibitory effects of flavonoids on free radical-induced hemolysis and their oxidative effects on hemoglobin. Chem. Pharm. Bull. 52: 999–1001.
31. Kukreja, R.C. and Hess, M.L. (1992). The oxygen free radical system from equations through membrane–protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 26: 641–655.
32. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein measurement with Folin-phenol reagent. J. Biol. Chem. 193: 265–275.
33. Manning, A.S. and Hearse, D.J. (1984). Reperfusion-induced arrhythmias: mechanisms and prevention. J. Mol. Cell Cardiol. 16: 497–518.
34. Marczin, N., El-Habashi, N., Hoare, G.S., Bundy, R.E. and Yacoub, M. (2003). Antioxidants in myocardial ischemia–reperfusion injury: therapeutic potential and basic mechanisms. Arch. Biochem. Biophys. 420: 222–236.
35. Maxwell, S.R. (1995). Prospects for the use of antioxidant therapies. Drugs 49: 345–361.
36. Murugesan, M. and Manju, V. (2013). Luteolin a dietary flavonoid attenuates isoproterenol-induced myocardial oxidative stress in rat myocardium: An in vivo study. Biomed. Prevent. Nutri. 3: 159-164.
37. Niehaus, W.G. and Samuelson, B. (1968). Formation of malondialdehyde from phospholipid arachidonic during microsomal lipid peroxidation. Eur. J. Biochem. 6: 126–130.
38. Noronha-Dutra, A.A., Steen, E.M. and Woolf, N. (1985). The correlation between catecholamine and lipid peroxidation induced damage in heart cells. Basic Res. Cardiol. 80: 133–136.
39. Omaye, S.T., Turnbull, T.D. and Sauberlich, H.E. (1979). Selected method for the determination of ascorbic acid in animal cells, tissues and fluid. In: McCormic, D.B., Wright, D.L. (Eds.), Methods Enzymol, Academic press, New York 62: 3–11.
40. Park, J.L and Lucchesi, B.R. (1999). Mechanisms of myocardial reperfusion injury. Ann. Thorac. Surg. 68: 1905–1912.
41. Rahman, I. and Macnee, W. (1999). Lung glutathione and oxidative stress: implications in cigarette smoking-induced airway disease. Am. J. Physiol. 277: 1067–1088.
42. Rajadurai, M. and Prince, P.S.M. (2006). Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. Toxicol 22: 259–268.
43. Ravin, H.A. (1961). An improved colorimetric enzymatic assay of ceruloplasmin. J. Lab. Clin. Med. 58(1): 161-168.
44. Rotruck, J.T., Pope, A.L., Ganther, H.E. and Hoekstra, W.G. (1973). Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588–590.
45. Samokyszyn, V.M., Miller, D.M., Reif, D.W. and Aust, S.D. (1989). Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J. Biol. Chem. 264: 21–24.
46. Sesso, H.D., Gaziano, J.M., Liu, S. and Buring, J.E. (2003). Flavonoid intake and the risk of cardiovascular disease in women. Am. J. Clin. Nutr. 7: 1400–1408.
47. Sinha, K.A. (1972). Colorimetric assay of catalase. Anal. Biochem. 47: 389–394.
48. Sreedharan, V., Venkatachalam, K. and Namasivayam, N. (2009). Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis. Invest. Nw. Drugs 27(1): 21–30.
49. Subhash, S. and Subramanian, P. (2009). Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study. Mol. Cell Biochem. 327(1-2): 153–161.
50. Suchalatha, S. and Shyamala-Devi, C.S. (1990). Effect of Arogh–a polyherbal formulation on the marker enzymes in isoproterenol-induced myocardial injury. Indian J. Clin. Biochem. 19: 184–189.
51. 2+ transport. Arch. Biochem. Biophys. 387: 85–92.
52. Upston, J.M., Terentis, A.C. and Sticker, R. (1999). Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J. 13: 977–994.
53. Wu, T.W., Zeng, L.H., Wu, J. and Fung, K.P. (1993). Morin hydrate is a plant-derived and antioxidant-based hepatoprotector. Life Sci. 53: 213–218.
54. Wu, T.W., Zeng, L.H., Wu, J. and Fung, K.P. (1994). Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage. Biochem. Pharmacol. 47: 1099–1103.
55. Zweier, J.L. and Villamena, F.A. (2003). Chemistry of free radicals in biological systems. In: Kukin, M.L., Fuster, V., editors. Oxidative stress and cardiac failure. Armonk, N.Y.’ Futura Publishing Company, Inc.67–95.